scholarly article | Q13442814 |
retracted paper | Q45182324 |
P356 | DOI | 10.1089/GTMB.2017.0113 |
P698 | PubMed publication ID | 29172775 |
P2093 | author name string | Pan Li | |
Li Wang | |||
Yuanyuan Ji | |||
Guozhong Jiang | |||
Haijun Yang | |||
Junkuo Li | |||
P2860 | cites work | AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration | Q39969417 |
Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. | Q41252117 | ||
Colorectal cancer | Q57191694 | ||
Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer | Q73666651 | ||
Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer | Q73981581 | ||
CCAAT/enhancer binding proteins in normal mammary development and breast cancer | Q24802403 | ||
Colorectal cancer: Metastases to a single organ | Q26778009 | ||
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer | Q27004958 | ||
Cancer treatment and survivorship statistics, 2012 | Q27020961 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Cancer statistics, 2012 | Q27860574 | ||
Matrix metalloproteinases in tumor invasion | Q28144147 | ||
Cancer treatment and survivorship statistics, 2014 | Q29617702 | ||
Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 | ||
How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies | Q31149571 | ||
C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells | Q33688502 | ||
Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins | Q34208771 | ||
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis | Q34249064 | ||
Colorectal cancer migration and invasion initiated by microRNA-106a | Q34389634 | ||
Colorectal cancer molecular biology moves into clinical practice | Q34425013 | ||
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q34664272 | ||
STAT3 regulates MMP3 in heme-induced endothelial cell apoptosis | Q34963885 | ||
CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases | Q34983912 | ||
The role of C/EBPbeta in mammary gland development and breast cancer | Q35592108 | ||
Role of matrix metalloproteinases (MMPs) in colorectal cancer | Q35682103 | ||
Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs | Q35741699 | ||
Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells | Q35845158 | ||
Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas | Q36140738 | ||
Matrix metalloproteinases: changing roles in tumor progression and metastasis | Q36422976 | ||
Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. | Q36540282 | ||
The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression | Q36617433 | ||
Matrix metalloproteinases and their clinical relevance in urinary bladder cancer | Q37864524 | ||
Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer | Q37871441 | ||
CCAAT enhancer binding protein-beta regulates matrix metalloproteinase-1 expression in interleukin-1beta-stimulated A549 lung carcinoma cells | Q38350896 | ||
C/EBPβ Mediates TNF-α-Induced Cancer Cell Migration by Inducing MMP Expression Dependent on p38 MAPK. | Q38877112 | ||
CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis. | Q39473856 | ||
Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells | Q39615781 | ||
Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. | Q39937065 | ||
P921 | main subject | colorectal cancer | Q188874 |
P577 | publication date | 2017-11-27 | |
P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
P1476 | title | C/EBPβ Promotion of MMP3-Dependent Tumor Cell Invasion and Association with Metastasis in Colorectal Cancer |
Q104142674 | A Seven-NF-κB-Related Gene Signature May Distinguish Patients with Ulcerative Colitis-Associated Colorectal Carcinoma |
Q90640814 | A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor |
Q92997228 | CCAAT/Enhancer Binding Protein β-Mediated MMP3 Upregulation Promotes Esophageal Squamous Cell Cancer Invasion In Vitro and Is Associated with Metastasis in Human Patients |
Q90672520 | CCAAT/Enhancer-Binding Protein β Mediates Oxygen-Induced Retinal Neovascularization via Retinal Vascular Damage and Vascular Endothelial Growth Factor |
Q120508435 | Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis |
Q112640318 | Morbid Obesity in Women Is Associated with an Altered Intestinal Expression of Genes Related to Cancer Risk and Immune, Defensive, and Antimicrobial Response |
Q89763232 | P2X7R as an independent prognostic indicator in gastric cancer |
Q90326996 | Progress in Research on Tumor Metastasis Inhibitors |
Q112611423 | SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma |
Q91828628 | TNIP1 Inhibits Proliferation And Promotes Apoptosis In Clear Cell Renal Carcinoma Through Targeting C/Ebpβ |
Q91653810 | The role of P2X7 receptor in prognosis and metastasis of colorectal cancer |
Q93053563 | miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo |
Search more.